Skip to content

A Multicenter Randomized Controlled Study on the Effects of High Dietary Fiber Meal Replacement on Blood Glucose and Metabolic Improvements in Newly Diagnosed Type 2 Diabetes Patients with Obesity

A Multicenter Randomized Controlled Study on the Effects of High Dietary Fiber Meal Replacement on Blood Glucose and Metabolic Improvements in Newly Diagnosed Type 2 Diabetes Patients with Obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115457
Enrollment
Unknown
Registered
2025-12-26
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newly diagnosed T2DM

Interventions

Meal Replacement Group:High Dietary Fiber Meal Replacement

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. History of type 2 diabetes = 7.0 mmol/L, or 2-hour plasma glucose >= 11.1 mmol/L after a 75g oral glucose tolerance test; 3. Body Mass Index: 28 kg/m² = 18 and <= 75 years, regardless of gender; 5.Voluntarily participates in this trial and provides signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Acute cerebrovascular or cardiovascular event or myocardial infarction within the past 6 months; 2. Laboratory findings: Fasting C-peptide 3 times the upper limit of normal); severe renal impairment (eGFR = 180 mmHg and/or DBP >= 120 mmHg); 5. Individuals with severe hematological diseases; 6. Individuals comorbid with other endocrine system diseases, such as uncontrolled hyperthyroidism or Cushing's syndrome; 7. Individuals under stress conditions or with factors leading to secondary hyperglycemia (e.g., those taking glucocorticoids); 8. Pregnant or lactating women, or women planning pregnancy; 9. Individuals with potential allergy to the investigational product; 10. Participation in other food trials within the past 3 months; 11. Individuals unable to cooperate, such as those with psychiatric disorders; 12. Other conditions deemed by the investigator as unsuitable for participation.

Design outcomes

Primary

MeasureTime frame
HbA1c;

Secondary

MeasureTime frame
Blood pressure, body weight change, waist circumference, hip circumference, fat-free mass, total fat mass, muscle mass, body fat percentage, visceral fat area, basal metabolic rate, phase angle change;plasma metabolites;Blood routine test, liver and kidney function tests, urine routine test.;Quality of Life and Gastrointestinal Symptoms Questionnaire;Incidence of AE;Changes of GLU?INS?TG?TC?HDL-C?LDL-C?C-peptide levels;

Countries

China

Contacts

Public ContactWei Chen

Peking Union Medical College Hospital

chenw@pumch.cn+86 10 6915 4095

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026